Moderna (MRNA) Net Equity Issued and Repurchased (2018 - 2020)
Moderna (MRNA) posted quarterly Net Equity Issued and Repurchased of $1.3 billion for Q2 2020, up 136.91% on a QoQ basis from $550.0 million in Q1 2020.
Powered by 
Analysis
Moderna (MRNA) Net Equity Issued and Repurchased (2018 - 2020) Analysis & Trends
Moderna has reported Net Equity Issued and Repurchased for 2 years, with the latest figure at $1.3 billion in Q2 2020.
- Net Equity Issued and Repurchased for Q2 2020 came in at $1.3 billion, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was $1.3 billion (up 136.91% YoY), and the FY2020 annual result was $1.9 billion, changed N/A from the prior year.
- Net Equity Issued and Repurchased grew to $1.3 billion in Q2 2020, from $550.0 million in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $1.3 billion in Q2 2020 and troughed at $111.6 million in Q2 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 141.90 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Incyte | 25.44 Bn | 20.91 Bn | 1.57 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | 1.30 Bn |
| Mar 31, 2020 | 550.00 Mn |
| Jun 30, 2018 | 111.58 Mn |
| Mar 31, 2018 | 549.53 Mn |